芒果视频下载

精(jing)華制(zhi)藥集團股(gu)份有(you)限(xian)公司是由南(nan)通產控(kong)(kong)集團控(kong)(kong)股(gu)、國資(zi)監(jian)管的地(di)方國有(you)控(kong)(kong)股(gu)企業，由原南(nan)通中(zhong)誠制(zhi)藥有(you)限(xian)公司（南(nan)通中(zhong)藥廠(chang)(chang)(chang)）變更、重組南(nan)通制(zhi)藥總廠(chang)(chang)(chang)（南(nan)通制(zhi)藥廠(chang)(chang)(chang)、南(nan)通制(zhi)藥二廠(chang)(chang)(chang)）優質資(zi)源，并吸收民營資(zi)本南(nan)通綜藝投(tou)資(zi)有(you)限(xian)公司以及自然人(ren)投(tou)資(zi)設立。2010年2月在深(shen)交所中(zhong)小板掛(gua)牌上市，股(gu)票簡稱：精(jing)華制(zhi)藥，證券代(dai)號：002349。

公司已有(you)(you)(you)60多(duo)年(nian)的制(zhi)(zhi)藥(yao)(yao)(yao)歷(li)史(shi)，是(shi)一(yi)家(jia)綜(zong)合性的現代化(hua)GMP制(zhi)(zhi)藥(yao)(yao)(yao)有(you)(you)(you)限公司。目(mu)前擁有(you)(you)(you)7個(ge)(ge)子公司，是(shi)一(yi)家(jia)集中(zhong)(zhong)(zhong)藥(yao)(yao)(yao)制(zhi)(zhi)劑(ji)、中(zhong)(zhong)(zhong)藥(yao)(yao)(yao)飲(yin)片(pian)(pian)、西藥(yao)(yao)(yao)制(zhi)(zhi)劑(ji)、醫藥(yao)(yao)(yao)中(zhong)(zhong)(zhong)間體(ti)、化(hua)學原(yuan)料藥(yao)(yao)(yao)、生(sheng)物制(zhi)(zhi)藥(yao)(yao)(yao)、保健品(pin)(pin)(pin)等(deng)生(sheng)產(chan)、銷售和研發(fa)的綜(zong)合型制(zhi)(zhi)藥(yao)(yao)(yao)企業集團。公司有(you)(you)(you)中(zhong)(zhong)(zhong)西藥(yao)(yao)(yao)品(pin)(pin)(pin)種(zhong)200余(yu)種(zhong)，中(zhong)(zhong)(zhong)藥(yao)(yao)(yao)產(chan)品(pin)(pin)(pin)主(zhu)要有(you)(you)(you)享譽海(hai)內外的經典名藥(yao)(yao)(yao)“五朵(duo)金(jin)花”王氏保赤(chi)丸(wan)(wan)、季(ji)德(de)(de)勝(sheng)蛇藥(yao)(yao)(yao)片(pian)(pian)、正柴胡(hu)飲(yin)顆(ke)粒、大柴胡(hu)顆(ke)粒、金(jin)蕎麥膠(jiao)囊，以及固(gu)本咳喘片(pian)(pian)、暈(yun)可平(ping)糖漿、精血補片(pian)(pian)等(deng)，這些中(zhong)(zhong)(zhong)藥(yao)(yao)(yao)品(pin)(pin)(pin)種(zhong)都有(you)(you)(you)著(zhu)廣(guang)泛的歷(li)史(shi)背景及深厚的文化(hua)底蘊，其(qi)中(zhong)(zhong)(zhong)季(ji)德(de)(de)勝(sheng)蛇藥(yao)(yao)(yao)片(pian)(pian)、王氏保赤(chi)丸(wan)(wan)制(zhi)(zhi)作(zuo)技(ji)藝(yi)均被列入國(guo)家(jia)非(fei)物質文化(hua)遺(yi)產(chan)。原(yuan)料藥(yao)(yao)(yao)產(chan)品(pin)(pin)(pin)主(zhu)要有(you)(you)(you)苯巴比妥、撲米酮、氟(fu)尿嘧(mi)(mi)啶、保泰松、氟(fu)胞嘧(mi)(mi)啶、吡羅昔康(kang)、替諾昔康(kang)、丙(bing)硫(liu)氧(yang)嘧(mi)(mi)啶、非(fei)那西丁、雙嘧(mi)(mi)達莫以及其(qi)它(ta)醫藥(yao)(yao)(yao)中(zhong)(zhong)(zhong)間體(ti)等(deng)。其(qi)中(zhong)(zhong)(zhong)已有(you)(you)(you)10個(ge)(ge)品(pin)(pin)(pin)種(zhong)通(tong)(tong)過國(guo)家(jia)GMP認(ren)(ren)證，5個(ge)(ge)品(pin)(pin)(pin)種(zhong)通(tong)(tong)過歐(ou)盟CEP認(ren)(ren)證，2個(ge)(ge)品(pin)(pin)(pin)種(zhong)通(tong)(tong)過澳大利亞(ya)GMP認(ren)(ren)證，3個(ge)(ge)品(pin)(pin)(pin)種(zhong)通(tong)(tong)過墨西哥官方認(ren)(ren)證，4個(ge)(ge)品(pin)(pin)(pin)種(zhong)獲(huo)得美(mei)國(guo)DMF注(zhu)冊文件(jian) ，1個(ge)(ge)品(pin)(pin)(pin)種(zhong)獲(huo)得美(mei)國(guo)VMF注(zhu)冊文件(jian)，并已通(tong)(tong)過美(mei)國(guo)FDA現場核查。

精華制藥將會以(yi)(yi)“成為(wei)(wei)以(yi)(yi)傳(chuan)世中藥為(wei)(wei)核(he)(he)心(xin)特色的(de)(de)全國(guo)現代醫(yi)(yi)藥企業(ye)”為(wei)(wei)戰略目標，深入貫徹《關于促進中醫(yi)(yi)藥傳(chuan)承創新(xin)發展(zhan)的(de)(de)意(yi)見》精神，聚焦“五朵(duo)金花”傳(chuan)世中藥主業(ye)為(wei)(wei)主，特色化學原料(liao)藥及化學制劑為(wei)(wei)輔的(de)(de)“雙輪驅動”的(de)(de)發展(zhan)戰略，依托品(pin)牌力和渠道力，致力于成為(wei)(wei)以(yi)(yi)傳(chuan)世中藥為(wei)(wei)核(he)(he)心(xin)特色的(de)(de)全國(guo)現代醫(yi)(yi)藥企業(ye)。